UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Effect of Time-Restricted Eating on Insulin Levels and Insulin Sensitivity in Patients with Polycystic Ovarian Syndrome: A Systematic Review

International journal of endocrinology, 2022-09, Vol.2022, p.1-13

2022

Volltextzugriff (PDF)

UGT1A1 promoter polymorphism increases risk of nilotinib-induced hyperbilirubinemia

Leukemia, 2007-11, Vol.21 (11), p.2311-2315

2007

Volltextzugriff (PDF)

Algebraic and Combinatorial Computational Biology

1, 2018

Volltextzugriff (PDF)

Results of the GEOMETRY mono-1 phase II study for evaluation of the MET inhibitor capmatinib (INC280) in patients (pts) with METΔex14 mutated advanced non-small cell lung cancer (NSCLC)

Annals of oncology, 2018-10, Vol.29, p.viii741-viii742

2018

Volltextzugriff (PDF)

Algebraic and Discrete Mathematical Methods for Modern Biology

Robeva, Raina

1, 2015

Volltextzugriff (PDF)

Serum Amyloid A (apoSAA) Expression Is Up-Regulated in Rheumatoid Arthritis and Induces Transcription of Matrix Metalloproteinases

The Journal of immunology (1950), 2001-02, Vol.166 (4), p.2801-2807

2001

Volltextzugriff (PDF)

Characterization of human A(2B) adenosine receptors: radioligand binding, western blotting, and coupling to G(q) in human embryonic kidney 293 cells and HMC-1 mast cells

Molecular pharmacology, 1999-10, Vol.56 (4), p.705-713

1999

Volltextzugriff (PDF)

Molecular cloning and functional expression of a sheep A3 adenosine receptor with widespread tissue distribution

Molecular pharmacology, 1993-09, Vol.44 (3), p.524-532

1993

Volltextzugriff (PDF)

Does an Association between the Idiopathic Left-Sided Varicocele and Eye Colour Exist?

Advances in Urology, 2014-01, Vol.2014 (2014), p.126-129

2014

Volltextzugriff (PDF)

986P Response to capmatinib in patients (pts) with advanced non-small cell lung cancer (NSCLC) and MET exon 14 skipping (METex14) mutation: Whole transcriptome analysis from phase II GEOMETRY Mono-1 study

Annals of oncology, 2022-09, Vol.33, p.S1003

2022

Volltextzugriff (PDF)

26P Capmatinib in treatment (Tx)-naive MET exon 14-mutated (METex14) advanced non-small cell lung Cancer (aNSCLC): Updated results from GEOMETRY mono-1

Annals of oncology, 2022-04, Vol.33, p.S42

2022

Volltextzugriff (PDF)

1391P Capmatinib vs docetaxel as second- or third-line (2/3L) therapy in patients (pts) with METex14-mutated advanced NSCLC (aNSCLC): The GeoMETry-III trial

Annals of oncology, 2023-10, Vol.34, p.S797-S797

2023

Volltextzugriff (PDF)

Absence of an effect of a single-dose deferasirox on the steady-state pharmacokinetics of digoxin

International journal of clinical pharmacology and therapeutics, 2008-10, Vol.46 (10), p.519-526

2008

Volltextzugriff (PDF)

1256P Capmatinib safety update in MET dysregulated NSCLC from the GEOMETRY mono-1 trial

Annals of oncology, 2021-09, Vol.32, p.S986-S987

2021

Volltextzugriff (PDF)

Mathematical Concepts and Methods in Modern Biology: Using Modern Discrete Models

1, 2013

Volltextzugriff (PDF)

Capmatinib response in patients with advanced non–small cell lung cancer (NSCLC) harboring focal MET amplifications: Analysis from the phase 2, multicohort GEOMETRY mono-1 study

European journal of cancer (1990), 2022-10, Vol.174, p.S21-S21

2022

Volltextzugriff (PDF)

1285P Capmatinib in patients with METex14-mutated advanced non-small cell lung cancer who received prior immunotherapy: The phase II GEOMETRY mono-1 study

Annals of oncology, 2020-09, Vol.31, p.S830-S830

2020

Volltextzugriff (PDF)

MO01.21 Phase 2 GEOMETRY Mono-1 Study: Capmatinib in Patients with METex14-mutated Advanced Non-Small Cell Lung Cancer who Received Prior Immunotherapy

Journal of thoracic oncology, 2021-01, Vol.16 (1), p.S24-S25

2021

Volltextzugriff (PDF)

Nogo-A Inhibits Neurite Outgrowth and Cell Spreading with Three Discrete Regions

The Journal of neuroscience, 2003-07, Vol.23 (13), p.5393-5406

2003

Volltextzugriff (PDF)

Double tagging recombinant A1- and A2A-adenosine receptors with hexahistidine and the FLAG epitope : Development of an efficient generic protein purification procedure

Biochemical pharmacology, 1996-02, Vol.51 (4), p.545-555

1996

Volltextzugriff (PDF)

P85.04 Capmatinib in Patients with METex14-Mutated Non-Small Cell Lung Cancer: GEOMETRY Mono-1 Asian Subgroup Analysis

Journal of thoracic oncology, 2021-03, Vol.16 (3), p.S670-S670

2021

Volltextzugriff (PDF)

OA01.07 Capmatinib (INC280) in METΔEX14-Mutated Advanced NSCLC: Efficacy Data from the Phase 2 Geometry MONO-1 Study

Journal of thoracic oncology, 2019-11, Vol.14 (11), p.S1126-S1126

2019

Volltextzugriff (PDF)

LBA52Results of the GEOMETRY mono-1 phase II study for evaluation of the MET inhibitor capmatinib (INC280) in patients (pts) with METΔex14 mutated advanced non-small cell lung cancer (NSCLC)

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

BioModel Engineering with Petri Nets

Algebraic and Discrete Mathematical Methods for Modern Biology, 2015

Robeva, Raina

2015

Volltextzugriff (PDF)

Inhibition of contact hypersensitivity reaction to picryl chloride: effect of small molecular weight peptidomimetic compounds possessing inhibitory activity against metalloproteinases

International immunopharmacology, 2002-04, Vol.2 (5), p.699-710

2002

Volltextzugriff (PDF)

1 – 25 von 306

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(215)
Mit Volltextzugriff
(165)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

The Effect of Time-Restricted Eating on Insulin Levels and Insulin Sensitivity in Patients with Polycystic Ovarian Syndrome: A Systematic Review

UGT1A1 promoter polymorphism increases risk of nilotinib-induced hyperbilirubinemia

Algebraic and Combinatorial Computational Biology

Results of the GEOMETRY mono-1 phase II study for evaluation of the MET inhibitor capmatinib (INC280) in patients (pts) with METΔex14 mutated advanced non-small cell lung cancer (NSCLC)

Algebraic and Discrete Mathematical Methods for Modern Biology

Serum Amyloid A (apoSAA) Expression Is Up-Regulated in Rheumatoid Arthritis and Induces Transcription of Matrix Metalloproteinases

Characterization of human A(2B) adenosine receptors: radioligand binding, western blotting, and coupling to G(q) in human embryonic kidney 293 cells and HMC-1 mast cells

Molecular cloning and functional expression of a sheep A3 adenosine receptor with widespread tissue distribution

Does an Association between the Idiopathic Left-Sided Varicocele and Eye Colour Exist?

986P Response to capmatinib in patients (pts) with advanced non-small cell lung cancer (NSCLC) and MET exon 14 skipping (METex14) mutation: Whole transcriptome analysis from phase II GEOMETRY Mono-1 study

26P Capmatinib in treatment (Tx)-naive MET exon 14-mutated (METex14) advanced non-small cell lung Cancer (aNSCLC): Updated results from GEOMETRY mono-1

1391P Capmatinib vs docetaxel as second- or third-line (2/3L) therapy in patients (pts) with METex14-mutated advanced NSCLC (aNSCLC): The GeoMETry-III trial

Absence of an effect of a single-dose deferasirox on the steady-state pharmacokinetics of digoxin

1256P Capmatinib safety update in MET dysregulated NSCLC from the GEOMETRY mono-1 trial

Mathematical Concepts and Methods in Modern Biology: Using Modern Discrete Models

Capmatinib response in patients with advanced non–small cell lung cancer (NSCLC) harboring focal MET amplifications: Analysis from the phase 2, multicohort GEOMETRY mono-1 study

1285P Capmatinib in patients with METex14-mutated advanced non-small cell lung cancer who received prior immunotherapy: The phase II GEOMETRY mono-1 study

MO01.21 Phase 2 GEOMETRY Mono-1 Study: Capmatinib in Patients with METex14-mutated Advanced Non-Small Cell Lung Cancer who Received Prior Immunotherapy

Nogo-A Inhibits Neurite Outgrowth and Cell Spreading with Three Discrete Regions

Double tagging recombinant A1- and A2A-adenosine receptors with hexahistidine and the FLAG epitope : Development of an efficient generic protein purification procedure

P85.04 Capmatinib in Patients with METex14-Mutated Non-Small Cell Lung Cancer: GEOMETRY Mono-1 Asian Subgroup Analysis

OA01.07 Capmatinib (INC280) in METΔEX14-Mutated Advanced NSCLC: Efficacy Data from the Phase 2 Geometry MONO-1 Study

LBA52Results of the GEOMETRY mono-1 phase II study for evaluation of the MET inhibitor capmatinib (INC280) in patients (pts) with METΔex14 mutated advanced non-small cell lung cancer (NSCLC)

BioModel Engineering with Petri Nets

Inhibition of contact hypersensitivity reaction to picryl chloride: effect of small molecular weight peptidomimetic compounds possessing inhibitory activity against metalloproteinases

Suchergebnisse filtern